Long-Term Safety and Effectiveness of OROS (Methylphenidate HCl) in Children With ADHD
Phase of Trial: Phase III
Latest Information Update: 01 Jun 2011
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Adverse reactions; Registrational
- Sponsors ALZA Corporation
- 23 Oct 2007 Status changed from in progress to completed.
- 19 Sep 2007 Status change
- 19 Nov 2006 New trial record.